Event Title

Sclerotherapy treatment of aneurysmal bone cysts

Session

Medicine and Nursing

Description

Aneurysmal bone cysts (ABCs) are benign bone lesions arising predominantly in the pediatric population that can cause local pain, swelling, and pathologic fracture. Primary lesions, which constitute roughly two thirds of all ABCs, are thought to be neoplastic in nature, with one third of ABCs arising secondary to other tumors. Diagnosis is made with various imaging modalities, which exhibit characteristic features such as “fluid-fluid levels,” although biopsy is critical, as telangiectatic osteosarcoma cannot be excluded based on imaging alone. Currently, the standard of care and most widely employed treatment is intralesional curettage. However, tumor recurrence with curettage alone is common and has driven some to propose a multitude of adjuvants with varying efficacy and risk profiles. Historically, therapies such as en bloc resection or radiation therapy were utilized as an alternative to decrease the recurrence rate, but these therapies imposed high morbidity. As a result, modern radiological techniques now seek to simultaneously reduce morbidity and recurrence. One such method is sclerotherapy of ABC with Aetosclerol 3% in several cycles that in our cases (4 patients) the effect was extremely good. The sclerotherapy was performed under CT guidance and local anaesthesia.

Keywords:

Aneurysmal bone cyst, Pediatric tumor, Benign bone tumor, sclerotherapy

Proceedings Editor

Edmond Hajrizi

ISBN

978-9951-550-47-5

Location

UBT Kampus, Lipjan

Start Date

30-10-2021 12:00 AM

End Date

30-10-2021 12:00 AM

DOI

10.33107/ubt-ic.2021.217

This document is currently not available here.

Share

COinS
 
Oct 30th, 12:00 AM Oct 30th, 12:00 AM

Sclerotherapy treatment of aneurysmal bone cysts

UBT Kampus, Lipjan

Aneurysmal bone cysts (ABCs) are benign bone lesions arising predominantly in the pediatric population that can cause local pain, swelling, and pathologic fracture. Primary lesions, which constitute roughly two thirds of all ABCs, are thought to be neoplastic in nature, with one third of ABCs arising secondary to other tumors. Diagnosis is made with various imaging modalities, which exhibit characteristic features such as “fluid-fluid levels,” although biopsy is critical, as telangiectatic osteosarcoma cannot be excluded based on imaging alone. Currently, the standard of care and most widely employed treatment is intralesional curettage. However, tumor recurrence with curettage alone is common and has driven some to propose a multitude of adjuvants with varying efficacy and risk profiles. Historically, therapies such as en bloc resection or radiation therapy were utilized as an alternative to decrease the recurrence rate, but these therapies imposed high morbidity. As a result, modern radiological techniques now seek to simultaneously reduce morbidity and recurrence. One such method is sclerotherapy of ABC with Aetosclerol 3% in several cycles that in our cases (4 patients) the effect was extremely good. The sclerotherapy was performed under CT guidance and local anaesthesia.